Combining DNA Damage Response Inhibitors with Immunotherapy Boosts SCLC Clearance, Mouse Study Shows - Immuno-Oncology News

Combining DNA Damage Response Inhibitors with Immunotherapy Boosts SCLC Clearance, Mouse Study Shows  Immuno-Oncology News

Combining PD-L1 and DNA damage response inhibitors significantly enhances anti-tumor immunity in mouse models of small cell lung cancer.